CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment
Recent CAN008 Phase 1 Follow-Up Data Showed 67% 5-Year Overall Survival in High-Dose Cohort, Reported…
Recent CAN008 Phase 1 Follow-Up Data Showed 67% 5-Year Overall Survival in High-Dose Cohort, Reported…
Safeguarding the health of up to 40,000 spectators at the first mask-off major sports event…
Supply chain transparency is critical to driving continuous improvement in environmental impact measurement and reporting…
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and…
Transaction marks KKR’s first hotel investment in Japan Builds on KKR’s strong momentum in Japan’s…
Xapo Banks marks a watershed moment for digital asset innovation by enabling members to bypass…
HAGUE, Netherlands & SYDNEY--(BUSINESS WIRE)--#IncidentManagement--Data Phase will work with Logsign in Australia and other parts…
THE WOODLANDS, Texas--(BUSINESS WIRE)--Excelerate Energy, Inc. (NYSE: EE) (the “Company” or “Excelerate”) today reported its…
Draganfly’s production capacity is coming on-line, enabling the Company to meet the growing demand and…
HAMILTON, Bermuda--(BUSINESS WIRE)--Everen Limited (Everen) held its March 2023 Board Meeting on Tuesday, March 21st…